BIOMARIN PHARMACEUTICAL INC Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent
BIOMARIN PHARMACEUTICAL INC (BMRN) reported Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent of -$4.55 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent · last filed 2026-08-06
- BIOMARIN PHARMACEUTICAL INC other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2026-06-30 was -$4.55M.
- BIOMARIN PHARMACEUTICAL INC other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2026-03-31 was $9.24M.
- BIOMARIN PHARMACEUTICAL INC other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2025-12-31 was $20.46M, a 64.10% decline year-over-year.
- BIOMARIN PHARMACEUTICAL INC other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2025-09-30 was $10.63M.
- BIOMARIN PHARMACEUTICAL INC other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2025 was -$75.13M, a 183.07% decline from fiscal 2024.
- BIOMARIN PHARMACEUTICAL INC other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2024 was $90.44M.
- BIOMARIN PHARMACEUTICAL INC other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2023 was -$24.92M.
- BIOMARIN PHARMACEUTICAL INC other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2022 was -$18.30M, a 159.86% decline from fiscal 2021.
| Period end | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 3 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 6 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 9 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$4.55M 10-Q · filed 2026-08-06 | $4.69M 10-Q · filed 2026-08-06 | $25.15M derived: sum of 3 quarters · filed 2026-08-06 | $35.78M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $9.24M 10-Q · filed 2026-05-05 | $29.70M derived: sum of 2 quarters · filed 2026-05-05 | $40.33M derived: sum of 3 quarters · filed 2026-05-05 | -$23.39M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $20.46M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $31.09M derived: sum of 2 quarters · filed 2026-02-26 | -$32.62M derived: sum of 3 quarters · filed 2026-08-06 | -$75.13M 10-K · filed 2026-02-26 |
| 2025-09-30 | $10.63M 10-Q · filed 2025-10-28 | -$53.09M derived: sum of 2 quarters · filed 2026-08-06 | -$95.59M 10-Q · filed 2025-10-28 | -$38.59M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | -$63.72M 10-Q · filed 2026-08-06 | -$106.22M 10-Q · filed 2026-08-06 | -$49.22M derived: sum of 3 quarters · filed 2026-08-06 | -$71.36M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | -$42.50M 10-Q · filed 2026-05-05 | $14.50M derived: sum of 2 quarters · filed 2026-05-05 | -$7.65M derived: sum of 3 quarters · filed 2026-05-05 | $20.20M derived: sum of 4 quarters · filed 2026-05-05 |
| 2024-12-31 | $57.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $34.85M derived: sum of 2 quarters · filed 2026-02-26 | $62.70M derived: sum of 3 quarters · filed 2026-02-26 | $90.44M 10-K · filed 2026-02-26 |
| 2024-09-30 | -$22.15M 10-Q · filed 2025-10-28 | $5.70M derived: sum of 2 quarters · filed 2025-10-28 | $33.44M 10-Q · filed 2025-10-28 | -$1.61M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | $27.84M 10-Q · filed 2025-08-05 | $55.59M 10-Q · filed 2025-08-05 | $20.54M derived: sum of 3 quarters · filed 2026-02-26 | $45.42M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | $27.74M 10-Q · filed 2025-05-02 | -$7.30M derived: sum of 2 quarters · filed 2026-02-26 | $17.57M derived: sum of 3 quarters · filed 2026-02-26 | $9.68M derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | -$35.05M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$10.17M derived: sum of 2 quarters · filed 2026-02-26 | -$18.07M derived: sum of 3 quarters · filed 2026-02-26 | -$24.92M 10-K · filed 2026-02-26 |
| 2023-09-30 | $24.87M 10-Q · filed 2024-10-31 | $16.98M derived: sum of 2 quarters · filed 2024-10-31 | $10.12M 10-Q · filed 2024-10-31 | -$24.49M derived: sum of 4 quarters · filed 2025-02-24 |
| 2023-06-30 | -$7.89M 10-Q · filed 2024-08-05 | -$14.75M 10-Q · filed 2024-08-05 | -$49.37M derived: sum of 3 quarters · filed 2025-02-24 | -$37.09M derived: sum of 4 quarters · filed 2025-02-24 |
| 2023-03-31 | -$6.86M 10-Q · filed 2024-04-26 | -$41.47M derived: sum of 2 quarters · filed 2025-02-24 | -$29.19M derived: sum of 3 quarters · filed 2025-02-24 | -$9.85M derived: sum of 4 quarters · filed 2025-02-24 |
| 2022-12-31 | -$34.62M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-24 | -$22.34M derived: sum of 2 quarters · filed 2025-02-24 | -$2.99M derived: sum of 3 quarters · filed 2025-02-24 | -$18.30M 10-K · filed 2025-02-24 |
| 2022-09-30 | $12.28M 10-Q · filed 2023-11-02 | $31.63M derived: sum of 2 quarters · filed 2023-11-02 | $16.32M 10-Q · filed 2023-11-02 | $20.51M derived: sum of 4 quarters · filed 2024-02-26 |
| 2022-06-30 | $19.35M 10-Q · filed 2023-08-02 | $4.04M 10-Q · filed 2023-08-02 | $8.23M derived: sum of 3 quarters · filed 2024-02-26 | $19.41M derived: sum of 4 quarters · filed 2024-02-26 |
| 2022-03-31 | -$15.31M 10-Q · filed 2023-04-28 | -$11.12M derived: sum of 2 quarters · filed 2024-02-26 | $62.00K derived: sum of 3 quarters · filed 2024-02-26 | -$5.88M derived: sum of 4 quarters · filed 2024-02-26 |
| 2021-12-31 | $4.19M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-26 | $15.37M derived: sum of 2 quarters · filed 2024-02-26 | $9.43M derived: sum of 3 quarters · filed 2024-02-26 | $30.57M 10-K · filed 2024-02-26 |
| 2021-09-30 | $11.18M 10-Q · filed 2022-10-28 | $5.24M derived: sum of 2 quarters · filed 2022-10-28 | $26.38M 10-Q · filed 2022-10-28 | -$146.00K derived: sum of 4 quarters · filed 2023-02-27 |
| 2021-06-30 | -$5.94M 10-Q · filed 2022-08-04 | $15.20M 10-Q · filed 2022-08-04 | -$11.32M derived: sum of 3 quarters · filed 2023-02-27 | -$30.99M derived: sum of 4 quarters · filed 2023-02-27 |
| 2021-03-31 | $21.14M 10-Q · filed 2022-04-29 | -$5.38M derived: sum of 2 quarters · filed 2023-02-27 | -$25.05M derived: sum of 3 quarters · filed 2023-02-27 | -$29.12M derived: sum of 4 quarters · filed 2023-02-27 |
| 2020-12-31 | -$26.52M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-27 | -$46.19M derived: sum of 2 quarters · filed 2023-02-27 | -$50.27M derived: sum of 3 quarters · filed 2023-02-27 | -$36.30M 10-K · filed 2023-02-27 |
| 2020-09-30 | -$19.66M 10-Q · filed 2021-10-29 | -$23.74M derived: sum of 2 quarters · filed 2021-10-29 | -$9.78M 10-Q · filed 2021-10-29 | -$26.62M derived: sum of 4 quarters · filed 2022-02-25 |
| 2020-06-30 | -$4.08M 10-Q · filed 2021-07-30 | $9.89M 10-Q · filed 2021-07-30 | -$6.95M derived: sum of 3 quarters · filed 2022-02-25 | $12.61M derived: sum of 4 quarters · filed 2022-02-25 |
| 2020-03-31 | $13.96M 10-Q · filed 2021-04-30 | -$2.88M derived: sum of 2 quarters · filed 2022-02-25 | $16.69M derived: sum of 3 quarters · filed 2022-02-25 | $14.33M derived: sum of 4 quarters · filed 2022-02-25 |
| 2019-12-31 | -$16.84M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-25 | $2.73M derived: sum of 2 quarters · filed 2022-02-25 | $370.00K derived: sum of 3 quarters · filed 2022-02-25 | $14.89M 10-K · filed 2022-02-25 |
| 2019-09-30 | $19.56M 10-Q · filed 2020-11-06 | $17.21M derived: sum of 2 quarters · filed 2020-11-06 | $31.73M 10-Q · filed 2020-11-06 | $39.16M derived: sum of 4 quarters · filed 2021-02-26 |
| 2019-06-30 | -$2.35M 10-Q · filed 2020-08-05 | $12.17M 10-Q · filed 2020-08-05 | $19.60M derived: sum of 3 quarters · filed 2021-02-26 | $18.57M derived: sum of 4 quarters · filed 2021-02-26 |
| 2019-03-31 | $14.52M 10-Q · filed 2020-05-01 | $21.95M derived: sum of 2 quarters · filed 2021-02-26 | $20.92M derived: sum of 3 quarters · filed 2021-02-26 | $48.34M derived: sum of 4 quarters · filed 2021-02-26 |
| 2018-12-31 | $7.43M derived: 10-K 12 month − 10-Q/A 9 month · filed 2021-02-26 | $6.40M derived: sum of 2 quarters · filed 2021-02-26 | $33.82M derived: sum of 3 quarters · filed 2021-02-26 | $28.82M 10-K · filed 2021-02-26 |
| 2018-09-30 | -$1.03M 10-Q/A · filed 2019-11-04 | $26.39M derived: sum of 2 quarters · filed 2019-11-04 | $21.39M 10-Q/A · filed 2019-11-04 | $19.86M derived: sum of 4 quarters · filed 2019-11-04 |
| 2018-06-30 | $27.42M 10-Q · filed 2019-08-02 | $22.42M 10-Q · filed 2019-08-02 | $20.89M derived: sum of 3 quarters · filed 2019-08-02 | $14.12M derived: sum of 4 quarters · filed 2019-08-02 |
| 2018-03-31 | -$5.00M 10-Q · filed 2019-04-29 | -$6.53M derived: sum of 2 quarters · filed 2019-04-29 | -$13.30M derived: sum of 3 quarters · filed 2019-04-29 | -$32.98M derived: sum of 4 quarters · filed 2019-04-29 |
| 2017-12-31 | -$1.53M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28 | -$8.30M derived: sum of 2 quarters · filed 2019-02-28 | -$27.98M derived: sum of 3 quarters · filed 2019-02-28 | -$35.78M 10-K · filed 2019-02-28 |
| 2017-09-30 | -$6.78M 10-Q · filed 2018-10-26 | -$26.45M derived: sum of 2 quarters · filed 2018-10-26 | -$34.25M 10-Q · filed 2018-10-26 | -$23.59M derived: sum of 4 quarters · filed 2018-10-26 |
| 2017-06-30 | -$19.68M 10-Q · filed 2018-08-03 | -$27.47M 10-Q · filed 2018-08-03 | -$16.82M derived: sum of 3 quarters · filed 2018-08-03 | -$19.19M derived: sum of 4 quarters · filed 2018-08-03 |
| 2017-03-31 | -$7.80M 10-Q · filed 2018-04-27 | $2.86M derived: sum of 2 quarters · filed 2018-04-27 | $492.00K derived: sum of 3 quarters · filed 2018-04-27 | $4.97M derived: sum of 4 quarters · filed 2018-04-27 |
| 2016-12-31 | $10.66M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-26 | $8.29M derived: sum of 2 quarters · filed 2018-02-26 | $12.77M derived: sum of 3 quarters · filed 2018-02-26 | -$8.22M 10-K · filed 2018-02-26 |
| 2016-09-30 | -$2.37M 10-Q · filed 2017-10-31 | $2.11M derived: sum of 2 quarters · filed 2017-10-31 | -$18.88M 10-Q · filed 2017-10-31 | -$23.03M derived: sum of 4 quarters · filed 2017-10-31 |
| 2016-06-30 | $4.48M 10-Q · filed 2017-08-02 | -$16.50M 10-Q · filed 2017-08-02 | -$20.66M derived: sum of 3 quarters · filed 2017-08-02 | -$27.93M derived: sum of 4 quarters · filed 2017-08-02 |
| 2016-03-31 | -$20.99M 10-Q · filed 2017-05-04 | -$25.14M derived: sum of 2 quarters · filed 2017-05-04 | -$32.41M derived: sum of 3 quarters · filed 2017-05-04 | |
| 2015-12-31 | -$4.15M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-27 | -$11.43M derived: sum of 2 quarters · filed 2017-02-27 | -$6.43M 10-K · filed 2017-02-27 | |
| 2015-09-30 | -$7.28M 10-Q · filed 2016-11-03 | -$2.28M 10-Q · filed 2016-11-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |